HEADER HYDROLASE/INHIBITOR 28-JUN-23 8TBF
TITLE TRICOMPLEX OF RMC-7977, KRAS WT, AND CYPA
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: GTPASE KRAS;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: K-RAS 2,KI-RAS,C-K-RAS,C-KI-RAS;
COMPND 5 EC: 3.6.5.2;
COMPND 6 ENGINEERED: YES;
COMPND 7 MOL_ID: 2;
COMPND 8 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A;
COMPND 9 CHAIN: C, D;
COMPND 10 SYNONYM: PPIASE A,CYCLOPHILIN A,CYCLOSPORIN A-BINDING PROTEIN,
COMPND 11 ROTAMASE A;
COMPND 12 EC: 5.2.1.8;
COMPND 13 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: KRAS, KRAS2, RASK2;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 MOL_ID: 2;
SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 10 ORGANISM_COMMON: HUMAN;
SOURCE 11 ORGANISM_TAXID: 9606;
SOURCE 12 GENE: PPIA, CYPA;
SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS INHIBITOR, COMPLEX, SMALL GTPASE, CANCER, TRICOMPLEX, HYDROLASE-
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR A.C.A.TOMLINSON,A.CHEN,J.E.KNOX,J.K.YANO
REVDAT 4 05-JUN-24 8TBF 1 JRNL
REVDAT 3 24-APR-24 8TBF 1 JRNL
REVDAT 2 17-APR-24 8TBF 1 JRNL
REVDAT 1 07-FEB-24 8TBF 0
JRNL AUTH M.HOLDERFIELD,B.J.LEE,J.JIANG,A.TOMLINSON,K.J.SEAMON,A.MIRA,
JRNL AUTH 2 E.PATRUCCO,G.GOODHART,J.DILLY,Y.GINDIN,N.DINGLASAN,Y.WANG,
JRNL AUTH 3 L.P.LAI,S.CAI,L.JIANG,N.NASHOLM,N.SHIFRIN,C.BLAJ,H.SHAH,
JRNL AUTH 4 J.W.EVANS,N.MONTAZER,O.LAI,J.SHI,E.AHLER,E.QUINTANA,S.CHANG,
JRNL AUTH 5 A.SALVADOR,A.MARQUEZ,J.CREGG,Y.LIU,A.MILIN,A.CHEN,T.B.ZIV,
JRNL AUTH 6 D.PARSONS,J.E.KNOX,J.E.KLOMP,J.ROTH,M.REES,M.RONAN,
JRNL AUTH 7 A.CUEVAS-NAVARRO,F.HU,P.LITO,D.SANTAMARIA,A.J.AGUIRRE,
JRNL AUTH 8 A.M.WATERS,C.J.DER,C.AMBROGIO,Z.WANG,A.L.GILL,E.S.KOLTUN,
JRNL AUTH 9 J.A.M.SMITH,D.WILDES,M.SINGH
JRNL TITL CONCURRENT INHIBITION OF ONCOGENIC AND WILD-TYPE RAS-GTP FOR
JRNL TITL 2 CANCER THERAPY.
JRNL REF NATURE V. 629 919 2024
JRNL REFN ESSN 1476-4687
JRNL PMID 38589574
JRNL DOI 10.1038/S41586-024-07205-6
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH J.JIANG,L.JIANG,B.J.MALDONATO,Y.WANG,M.HOLDERFIELD,
REMARK 1 AUTH 2 I.ARONCHIK,I.P.WINTERS,Z.SALMAN,C.BLAJ,M.MENARD,J.BRODBECK,
REMARK 1 AUTH 3 Z.CHEN,X.WEI,M.J.ROSEN,Y.GINDIN,B.J.LEE,J.W.EVANS,S.CHANG,
REMARK 1 AUTH 4 Z.WANG,K.J.SEAMON,D.PARSONS,J.CREGG,A.MARQUEZ,
REMARK 1 AUTH 5 A.C.A.TOMLINSON,J.K.YANO,J.E.KNOX,E.QUINTANA,A.J.AGUIRRE,
REMARK 1 AUTH 6 K.C.ARBOUR,A.REED,W.C.GUSTAFSON,A.L.GILL,E.S.KOLTUN,
REMARK 1 AUTH 7 D.WILDES,J.A.M.SMITH,Z.WANG,M.SINGH
REMARK 1 TITL TRANSLATIONAL AND THERAPEUTIC EVALUATION OF RAS-GTP
REMARK 1 TITL 2 INHIBITION BY RMC-6236 IN RAS-DRIVEN CANCERS.
REMARK 1 REF CANCER DISCOV OF1 2024
REMARK 1 REFN ESSN 2159-8290
REMARK 1 PMID 38593348
REMARK 1 DOI 10.1158/2159-8290.CD-24-0027
REMARK 2
REMARK 2 RESOLUTION. 1.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX 1.17.1_3660
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.29
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 112256
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.179
REMARK 3 R VALUE (WORKING SET) : 0.178
REMARK 3 FREE R VALUE : 0.210
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910
REMARK 3 FREE R VALUE TEST SET COUNT : 5517
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 58.2900 - 4.6600 0.99 3782 193 0.1719 0.1840
REMARK 3 2 4.6600 - 3.7000 1.00 3655 200 0.1527 0.1822
REMARK 3 3 3.7000 - 3.2300 1.00 3646 181 0.1746 0.2071
REMARK 3 4 3.2300 - 2.9400 1.00 3622 188 0.1775 0.2251
REMARK 3 5 2.9400 - 2.7300 1.00 3593 192 0.1784 0.1849
REMARK 3 6 2.7300 - 2.5600 1.00 3606 172 0.1841 0.2307
REMARK 3 7 2.5600 - 2.4400 1.00 3584 176 0.1779 0.2323
REMARK 3 8 2.4400 - 2.3300 1.00 3565 180 0.1755 0.2359
REMARK 3 9 2.3300 - 2.2400 1.00 3602 183 0.1766 0.1924
REMARK 3 10 2.2400 - 2.1600 1.00 3534 194 0.1728 0.2332
REMARK 3 11 2.1600 - 2.1000 1.00 3565 186 0.1845 0.2228
REMARK 3 12 2.1000 - 2.0400 1.00 3563 186 0.1898 0.2377
REMARK 3 13 2.0400 - 1.9800 1.00 3544 166 0.1869 0.2237
REMARK 3 14 1.9800 - 1.9300 1.00 3536 184 0.1849 0.2066
REMARK 3 15 1.9300 - 1.8900 1.00 3589 175 0.1880 0.1762
REMARK 3 16 1.8900 - 1.8500 1.00 3528 174 0.1781 0.2168
REMARK 3 17 1.8500 - 1.8100 1.00 3555 181 0.1845 0.2224
REMARK 3 18 1.8100 - 1.7800 1.00 3499 182 0.1886 0.2050
REMARK 3 19 1.7800 - 1.7500 1.00 3550 190 0.1970 0.2396
REMARK 3 20 1.7500 - 1.7200 1.00 3512 192 0.1888 0.2260
REMARK 3 21 1.7200 - 1.6900 1.00 3522 188 0.1825 0.2210
REMARK 3 22 1.6900 - 1.6600 1.00 3544 183 0.1800 0.2057
REMARK 3 23 1.6600 - 1.6400 1.00 3496 186 0.1791 0.2160
REMARK 3 24 1.6400 - 1.6200 1.00 3533 169 0.1874 0.2298
REMARK 3 25 1.6200 - 1.5900 1.00 3476 195 0.1884 0.2129
REMARK 3 26 1.5900 - 1.5700 1.00 3528 193 0.1950 0.2110
REMARK 3 27 1.5700 - 1.5500 0.99 3531 178 0.1999 0.2485
REMARK 3 28 1.5500 - 1.5300 1.00 3486 186 0.2029 0.2483
REMARK 3 29 1.5300 - 1.5200 0.99 3488 178 0.2153 0.2755
REMARK 3 30 1.5200 - 1.5000 1.00 3505 186 0.2294 0.2781
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.147
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.771
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 17.58
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.56
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : 0.006 5650
REMARK 3 ANGLE : 0.939 7654
REMARK 3 CHIRALITY : 0.058 819
REMARK 3 PLANARITY : 0.005 984
REMARK 3 DIHEDRAL : 13.937 2174
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 4
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: (CHAIN 'A' AND RESID 0 THROUGH 169)
REMARK 3 ORIGIN FOR THE GROUP (A): 21.1441 -5.9975 -10.0257
REMARK 3 T TENSOR
REMARK 3 T11: 0.1079 T22: 0.0981
REMARK 3 T33: 0.1390 T12: -0.0272
REMARK 3 T13: 0.0317 T23: 0.0089
REMARK 3 L TENSOR
REMARK 3 L11: 1.8572 L22: 2.2938
REMARK 3 L33: 2.1224 L12: -0.3676
REMARK 3 L13: -0.2303 L23: 0.2968
REMARK 3 S TENSOR
REMARK 3 S11: 0.0854 S12: 0.0326 S13: 0.2535
REMARK 3 S21: -0.0144 S22: 0.0496 S23: -0.2022
REMARK 3 S31: -0.2205 S32: 0.1068 S33: -0.1063
REMARK 3 TLS GROUP : 2
REMARK 3 SELECTION: (CHAIN 'B' AND RESID 0 THROUGH 169)
REMARK 3 ORIGIN FOR THE GROUP (A): 17.4396 -23.5404 -42.3181
REMARK 3 T TENSOR
REMARK 3 T11: 0.3611 T22: 0.1915
REMARK 3 T33: 0.1584 T12: 0.0851
REMARK 3 T13: -0.0019 T23: -0.0022
REMARK 3 L TENSOR
REMARK 3 L11: 3.2725 L22: 3.6246
REMARK 3 L33: 2.7300 L12: -2.1692
REMARK 3 L13: 0.2566 L23: -0.2472
REMARK 3 S TENSOR
REMARK 3 S11: 0.4149 S12: 0.4929 S13: -0.0774
REMARK 3 S21: -0.9135 S22: -0.3301 S23: 0.1426
REMARK 3 S31: -0.0358 S32: 0.0165 S33: -0.0780
REMARK 3 TLS GROUP : 3
REMARK 3 SELECTION: (CHAIN 'C' AND RESID 1 THROUGH 164)
REMARK 3 ORIGIN FOR THE GROUP (A): -9.9042 -15.8396 -24.7485
REMARK 3 T TENSOR
REMARK 3 T11: 0.0803 T22: 0.1210
REMARK 3 T33: 0.0979 T12: 0.0142
REMARK 3 T13: 0.0030 T23: 0.0145
REMARK 3 L TENSOR
REMARK 3 L11: 1.8550 L22: 1.5870
REMARK 3 L33: 1.8282 L12: 0.5422
REMARK 3 L13: 0.1270 L23: -0.2456
REMARK 3 S TENSOR
REMARK 3 S11: 0.0894 S12: -0.1918 S13: -0.0622
REMARK 3 S21: 0.0188 S22: -0.1190 S23: 0.0868
REMARK 3 S31: 0.0719 S32: -0.0537 S33: 0.0261
REMARK 3 TLS GROUP : 4
REMARK 3 SELECTION: (CHAIN 'D' AND RESID 2 THROUGH 165)
REMARK 3 ORIGIN FOR THE GROUP (A): 24.4444 -39.1495 -10.0677
REMARK 3 T TENSOR
REMARK 3 T11: 0.1451 T22: 0.0770
REMARK 3 T33: 0.1101 T12: -0.0291
REMARK 3 T13: -0.0178 T23: -0.0045
REMARK 3 L TENSOR
REMARK 3 L11: 2.0324 L22: 0.9054
REMARK 3 L33: 2.0395 L12: 0.3149
REMARK 3 L13: 0.3590 L23: 0.1308
REMARK 3 S TENSOR
REMARK 3 S11: 0.0099 S12: -0.0116 S13: -0.2310
REMARK 3 S21: 0.0505 S22: 0.0256 S23: 0.0080
REMARK 3 S31: 0.3254 S32: -0.1501 S33: -0.0350
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 8TBF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-23.
REMARK 100 THE DEPOSITION ID IS D_1000275619.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 16-JUN-23
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 8.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : CLSI
REMARK 200 BEAMLINE : 08ID-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.95375
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 112271
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500
REMARK 200 RESOLUTION RANGE LOW (A) : 58.290
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 200 DATA REDUNDANCY : 7.300
REMARK 200 R MERGE (I) : 0.05881
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6
REMARK 200 DATA REDUNDANCY IN SHELL : 7.40
REMARK 200 R MERGE FOR SHELL (I) : 0.38870
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.540
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 47.15
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG4000, 0.1 M TRIS-HCL, PH 8.0,
REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.87850
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.99000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.12000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.99000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.87850
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.12000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER C 0
REMARK 465 SER D 0
REMARK 465 MET D 1
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 108 73.95 -114.78
REMARK 500 LYS A 117 34.56 70.63
REMARK 500 SER A 122 44.37 -97.13
REMARK 500 ASP B 108 71.84 -107.75
REMARK 500 LYS B 117 37.02 73.22
REMARK 500 SER B 122 48.00 -92.17
REMARK 500 PHE C 60 -68.01 -131.89
REMARK 500 ASN C 71 10.68 -144.13
REMARK 500 LYS C 133 -60.11 -98.06
REMARK 500 PHE D 60 -66.78 -133.33
REMARK 500 PHE D 60 -68.13 -133.33
REMARK 500
REMARK 500 REMARK: NULL
REMARK 525
REMARK 525 SOLVENT
REMARK 525
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE
REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 525
REMARK 525 M RES CSSEQI
REMARK 525 HOH B 478 DISTANCE = 5.83 ANGSTROMS
REMARK 525 HOH D 540 DISTANCE = 5.98 ANGSTROMS
REMARK 525 HOH D 541 DISTANCE = 6.19 ANGSTROMS
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG A 202 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 SER A 17 OG
REMARK 620 2 THR A 35 OG1 82.1
REMARK 620 3 GNP A 201 O1G 172.9 90.9
REMARK 620 4 GNP A 201 O2B 92.0 174.0 95.0
REMARK 620 5 HOH A 332 O 85.2 90.8 93.6 90.0
REMARK 620 6 HOH A 366 O 89.1 90.5 92.4 88.1 173.9
REMARK 620 N 1 2 3 4 5
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG B 202 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 SER B 17 OG
REMARK 620 2 THR B 35 OG1 86.9
REMARK 620 3 GNP B 201 O1G 174.5 92.2
REMARK 620 4 GNP B 201 O2B 89.1 176.0 91.7
REMARK 620 5 HOH B 329 O 86.2 95.6 88.5 83.9
REMARK 620 6 HOH B 334 O 92.0 92.1 93.5 88.2 171.9
REMARK 620 N 1 2 3 4 5
DBREF 8TBF A 1 169 UNP P01116 RASK_HUMAN 1 169
DBREF 8TBF B 1 169 UNP P01116 RASK_HUMAN 1 169
DBREF 8TBF C 1 165 UNP P62937 PPIA_HUMAN 1 165
DBREF 8TBF D 1 165 UNP P62937 PPIA_HUMAN 1 165
SEQADV 8TBF SER A 0 UNP P01116 EXPRESSION TAG
SEQADV 8TBF SER B 0 UNP P01116 EXPRESSION TAG
SEQADV 8TBF SER C 0 UNP P62937 EXPRESSION TAG
SEQADV 8TBF SER D 0 UNP P62937 EXPRESSION TAG
SEQRES 1 A 170 SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA GLY
SEQRES 2 A 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN
SEQRES 3 A 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP
SEQRES 4 A 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS
SEQRES 5 A 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR
SEQRES 6 A 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY
SEQRES 7 A 170 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE
SEQRES 8 A 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL
SEQRES 9 A 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN
SEQRES 10 A 170 LYS CYS ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN
SEQRES 11 A 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE
SEQRES 12 A 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA
SEQRES 13 A 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU
SEQRES 14 A 170 LYS
SEQRES 1 B 170 SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA GLY
SEQRES 2 B 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN
SEQRES 3 B 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP
SEQRES 4 B 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS
SEQRES 5 B 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR
SEQRES 6 B 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY
SEQRES 7 B 170 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE
SEQRES 8 B 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL
SEQRES 9 B 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN
SEQRES 10 B 170 LYS CYS ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN
SEQRES 11 B 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE
SEQRES 12 B 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA
SEQRES 13 B 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU
SEQRES 14 B 170 LYS
SEQRES 1 C 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL
SEQRES 2 C 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE
SEQRES 3 C 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA
SEQRES 4 C 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER
SEQRES 5 C 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY
SEQRES 6 C 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER
SEQRES 7 C 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU
SEQRES 8 C 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA
SEQRES 9 C 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR
SEQRES 10 C 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE
SEQRES 11 C 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET
SEQRES 12 C 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS
SEQRES 13 C 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU
SEQRES 1 D 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL
SEQRES 2 D 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE
SEQRES 3 D 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA
SEQRES 4 D 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER
SEQRES 5 D 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY
SEQRES 6 D 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER
SEQRES 7 D 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU
SEQRES 8 D 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA
SEQRES 9 D 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR
SEQRES 10 D 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE
SEQRES 11 D 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET
SEQRES 12 D 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS
SEQRES 13 D 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU
HET GNP A 201 32
HET MG A 202 1
HET GNP B 201 32
HET MG B 202 1
HET EDO C 201 4
HET ZNI C 202 62
HET ZNI D 201 62
HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER
HETNAM MG MAGNESIUM ION
HETNAM EDO 1,2-ETHANEDIOL
HETNAM ZNI (1R,5S,6R)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-
HETNAM 2 ZNI CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1-
HETNAM 3 ZNI METHOXYETHYL]PYRIDIN-3-YL}-21-ETHYL-17,17-DIMETHYL-8,
HETNAM 4 ZNI 14-DIOXO-15-OXA-4-THIA-9,21,27,28-
HETNAM 5 ZNI TETRAAZAPENTACYCLO[17.5.2.1~2,5~.1~9,13~.0~22,
HETNAM 6 ZNI 26~]OCTACOSA-1(24),2,5(28),19,22,25-HEXAEN-7-YL]-3-
HETNAM 7 ZNI OXABICYCLO[3.1.0]HEXANE-6-CARBOXAMIDE
HETSYN EDO ETHYLENE GLYCOL
HETSYN ZNI RMC-7977
FORMUL 5 GNP 2(C10 H17 N6 O13 P3)
FORMUL 6 MG 2(MG 2+)
FORMUL 9 EDO C2 H6 O2
FORMUL 10 ZNI 2(C47 H60 N8 O6 S)
FORMUL 12 HOH *933(H2 O)
HELIX 1 AA1 GLY A 15 ASN A 26 1 12
HELIX 2 AA2 GLN A 61 MET A 67 5 7
HELIX 3 AA3 ARG A 68 GLY A 75 1 8
HELIX 4 AA4 ASN A 86 ASP A 92 1 7
HELIX 5 AA5 ASP A 92 ASP A 105 1 14
HELIX 6 AA6 ASP A 126 GLY A 138 1 13
HELIX 7 AA7 GLY A 151 GLU A 168 1 18
HELIX 8 AA8 GLY B 15 ASN B 26 1 12
HELIX 9 AA9 GLN B 61 MET B 67 5 7
HELIX 10 AB1 ARG B 68 GLY B 75 1 8
HELIX 11 AB2 ASN B 86 ASP B 105 1 20
HELIX 12 AB3 ASP B 126 GLY B 138 1 13
HELIX 13 AB4 GLY B 151 GLU B 168 1 18
HELIX 14 AB5 VAL C 29 GLY C 42 1 14
HELIX 15 AB6 THR C 119 ASP C 123 5 5
HELIX 16 AB7 GLY C 135 GLU C 143 1 9
HELIX 17 AB8 ARG C 144 GLY C 146 5 3
HELIX 18 AB9 VAL D 29 GLY D 42 1 14
HELIX 19 AC1 THR D 119 ASP D 123 5 5
HELIX 20 AC2 GLY D 135 GLU D 143 1 9
HELIX 21 AC3 ARG D 144 GLY D 146 5 3
SHEET 1 AA1 6 GLU A 37 ILE A 46 0
SHEET 2 AA1 6 GLU A 49 THR A 58 -1 O LEU A 53 N LYS A 42
SHEET 3 AA1 6 THR A 2 GLY A 10 1 N TYR A 4 O ASP A 54
SHEET 4 AA1 6 GLY A 77 ALA A 83 1 O VAL A 81 N VAL A 9
SHEET 5 AA1 6 MET A 111 ASN A 116 1 O ASN A 116 N PHE A 82
SHEET 6 AA1 6 PHE A 141 GLU A 143 1 O ILE A 142 N LEU A 113
SHEET 1 AA2 6 GLU B 37 ILE B 46 0
SHEET 2 AA2 6 GLU B 49 THR B 58 -1 O LEU B 53 N LYS B 42
SHEET 3 AA2 6 THR B 2 GLY B 10 1 N TYR B 4 O ASP B 54
SHEET 4 AA2 6 GLY B 77 ALA B 83 1 O VAL B 81 N VAL B 9
SHEET 5 AA2 6 MET B 111 ASN B 116 1 O ASN B 116 N PHE B 82
SHEET 6 AA2 6 PHE B 141 GLU B 143 1 O ILE B 142 N LEU B 113
SHEET 1 AA3 8 ARG C 55 ILE C 57 0
SHEET 2 AA3 8 MET C 61 GLY C 64 -1 O GLN C 63 N ARG C 55
SHEET 3 AA3 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62
SHEET 4 AA3 8 ILE C 97 MET C 100 -1 N ILE C 97 O CYS C 115
SHEET 5 AA3 8 VAL C 128 GLU C 134 -1 O GLY C 130 N LEU C 98
SHEET 6 AA3 8 GLU C 15 LEU C 24 -1 N SER C 21 O LYS C 133
SHEET 7 AA3 8 THR C 5 VAL C 12 -1 N ILE C 10 O LEU C 17
SHEET 8 AA3 8 ILE C 156 GLU C 165 -1 O ASP C 160 N ASP C 9
SHEET 1 AA4 8 PHE D 53 ILE D 57 0
SHEET 2 AA4 8 MET D 61 GLY D 64 -1 O GLN D 63 N ARG D 55
SHEET 3 AA4 8 PHE D 112 CYS D 115 -1 O ILE D 114 N CYS D 62
SHEET 4 AA4 8 ILE D 97 MET D 100 -1 N ILE D 97 O CYS D 115
SHEET 5 AA4 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98
SHEET 6 AA4 8 GLU D 15 LEU D 24 -1 N SER D 21 O LYS D 133
SHEET 7 AA4 8 THR D 5 VAL D 12 -1 N ILE D 10 O GLY D 18
SHEET 8 AA4 8 ILE D 156 LEU D 164 -1 O ASP D 160 N ASP D 9
LINK OG SER A 17 MG MG A 202 1555 1555 2.07
LINK OG1 THR A 35 MG MG A 202 1555 1555 2.08
LINK O1G GNP A 201 MG MG A 202 1555 1555 2.02
LINK O2B GNP A 201 MG MG A 202 1555 1555 2.08
LINK MG MG A 202 O HOH A 332 1555 1555 2.07
LINK MG MG A 202 O HOH A 366 1555 1555 2.05
LINK OG SER B 17 MG MG B 202 1555 1555 1.99
LINK OG1 THR B 35 MG MG B 202 1555 1555 1.92
LINK O1G GNP B 201 MG MG B 202 1555 1555 2.03
LINK O2B GNP B 201 MG MG B 202 1555 1555 2.00
LINK MG MG B 202 O HOH B 329 1555 1555 2.18
LINK MG MG B 202 O HOH B 334 1555 1555 2.03
CRYST1 65.757 84.240 125.980 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.015208 0.000000 0.000000 0.00000
SCALE2 0.000000 0.011871 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007938 0.00000